{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:33:24Z","timestamp":1792528404213,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010031","name":"Postdoctoral Research Foundation of China","doi-asserted-by":"publisher","award":["2022M721452"],"award-info":[{"award-number":["2022M721452"]}],"id":[{"id":"10.13039\/501100010031","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Jiangxi Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["20232BAB206085"],"award-info":[{"award-number":["20232BAB206085"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Jiangxi Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["20224BAB216074"],"award-info":[{"award-number":["20224BAB216074"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Jiangxi Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["20232BAB216084"],"award-info":[{"award-number":["20232BAB216084"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.bioactmat.2024.10.029","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T22:55:05Z","timestamp":1731020105000},"page":"531-543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["\u03b2-Ketoenamine covalent organic framework nanoplatform combined with immune checkpoint blockade via photodynamic immunotherapy inhibit glioblastoma progression"],"prefix":"10.1016","volume":"44","author":[{"given":"Tengfeng","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuye","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanze","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzhe","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxin","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilei","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioactmat.2024.10.029_bib1","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.wneu.2017.09.104","article-title":"Prognostication of survival outcomes in patients diagnosed with glioblastoma","volume":"109","author":"Nizamutdinov","year":"2018","journal-title":"World Neurosurg"},{"issue":"7","key":"10.1016\/j.bioactmat.2024.10.029_bib2","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/jama.2023.0023","article-title":"Glioblastoma and other primary brain malignancies in adults: a review","volume":"329","author":"Schaff","year":"2023","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.bioactmat.2024.10.029_bib3","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion","volume":"8","author":"Dong","year":"2002","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.bioactmat.2024.10.029_bib4","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1056\/NEJMe1701182","article-title":"PD-1 and PD-L1 inhibitors as salvage therapy for urothelial carcinoma","volume":"376","author":"Sonpavde","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"7776","key":"10.1016\/j.bioactmat.2024.10.029_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41586-019-1593-5","article-title":"Harnessing innate immunity in cancer therapy","volume":"574","author":"Demaria","year":"2019","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bioactmat.2024.10.029_bib6","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/s41590-019-0433-y","article-title":"Mechanisms of immunotherapy resistance: lessons from glioblastoma","volume":"20","author":"Jackson","year":"2019","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.bioactmat.2024.10.029_bib7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s43018-023-00709-6","article-title":"Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial","volume":"5","author":"Bagley","year":"2024","journal-title":"Nat Cancer"},{"issue":"3","key":"10.1016\/j.bioactmat.2024.10.029_bib8","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41591-018-0339-5","article-title":"Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma","volume":"25","author":"Schalper","year":"2019","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.bioactmat.2024.10.029_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202205529","article-title":"Stellettin B sensitizes glioblastoma to DNA-damaging treatments by suppressing PI3K-mediated homologous recombination repair","volume":"10","author":"Peng","year":"2023","journal-title":"Adv. Sci."},{"issue":"10","key":"10.1016\/j.bioactmat.2024.10.029_bib10","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bioactmat.2024.10.029_bib11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-021-00431-4","article-title":"Programmed death ligand 1 signals in cancer cells","volume":"22","author":"Kornepati","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"7670","key":"10.1016\/j.bioactmat.2024.10.029_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature23643","article-title":"CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity","volume":"549","author":"Burr","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bioactmat.2024.10.029_bib13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.molcel.2019.09.030","article-title":"Mechanisms controlling PD-L1 expression in cancer","volume":"76","author":"Cha","year":"2019","journal-title":"Mol. Cell."},{"issue":"2","key":"10.1016\/j.bioactmat.2024.10.029_bib14","article-title":"Benzosceptrin C induces lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting DHHC3","volume":"5","author":"Wang","year":"2024","journal-title":"Cell Rep Med"},{"issue":"13","key":"10.1016\/j.bioactmat.2024.10.029_bib15","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2216796120","article-title":"O-GlcNAcylation promotes tumor immune evasion by inhibiting PD-L1 lysosomal degradation","volume":"120","author":"Zhu","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"14","key":"10.1016\/j.bioactmat.2024.10.029_bib16","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1038\/s41388-022-02237-6","article-title":"O-GlcNAc transferase regulates glioblastoma acetate metabolism via regulation of CDK5-dependent ACSS2 phosphorylation","volume":"41","author":"Ciraku","year":"2022","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.bioactmat.2024.10.029_bib17","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bioactmat.2024.10.029_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.bioactmat.2024.10.029_bib19","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"44","key":"10.1016\/j.bioactmat.2024.10.029_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303567","article-title":"A cholesterol metabolic regulated hydrogen-bonded organic framework (HOF)-based biotuner for antibody non-dependent immunotherapy tailored for glioblastoma","volume":"35","author":"Yin","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2024.10.029_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114036","article-title":"Phototherapy and optical waveguides for the treatment of infection","volume":"179","author":"Wang","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"16","key":"10.1016\/j.bioactmat.2024.10.029_bib22","doi-asserted-by":"crossref","first-page":"8814","DOI":"10.1021\/acs.chemrev.9b00550","article-title":"Covalent organic frameworks: design, synthesis, and functions","volume":"120","author":"Geng","year":"2020","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioactmat.2024.10.029_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2021.213957","article-title":"Covalent organic frameworks for fluorescent sensing: recent developments and future challenges","volume":"440","author":"Guo","year":"2021","journal-title":"Coord. Chem. Rev."},{"issue":"21","key":"10.1016\/j.bioactmat.2024.10.029_bib24","doi-asserted-by":"crossref","first-page":"13454","DOI":"10.1021\/acs.chemrev.1c00381","article-title":"Recent Strategies to develop innovative photosensitizers for enhanced photodynamic therapy","volume":"121","author":"Pham","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioactmat.2024.10.029_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ntm.2024.100034","article-title":"Photothermal\/photodynamic antibacterial hydrogel embedded with copper carbon dots and Au nanoparticles","volume":"3","author":"Lv","year":"2024","journal-title":"Nano TransMed"},{"issue":"48","key":"10.1016\/j.bioactmat.2024.10.029_bib26","doi-asserted-by":"crossref","first-page":"11103","DOI":"10.1039\/C9SC03040A","article-title":"Strong dual emission in covalent organic frameworks induced by ESIPT","volume":"10","author":"Yin","year":"2019","journal-title":"Chem. Sci."},{"issue":"12","key":"10.1016\/j.bioactmat.2024.10.029_bib27","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1021\/jacsau.3c00554","article-title":"Effect of ESIPT-induced photoisomerization of keto-enamine linkages on the photocatalytic hydrogen evolution performance of covalent organic frameworks","volume":"3","author":"Weng","year":"2023","journal-title":"JACS Au"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.10.029_bib28","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.1038\/s41467-023-41121-z","article-title":"Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.10.029_bib29","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1038\/s41467-022-33875-9","article-title":"Constitutional isomerism of the linkages in donor-acceptor covalent organic frameworks and its impact on photocatalysis","volume":"13","author":"Yang","year":"2022","journal-title":"Nat. Commun."},{"issue":"7904","key":"10.1016\/j.bioactmat.2024.10.029_bib30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41586-022-04443-4","article-title":"Reconstructed covalent organic frameworks","volume":"604","author":"Zhang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bioactmat.2024.10.029_bib31","article-title":"AIEgen-based covalent organic frameworks for preventing malignant ventricular arrhythmias via local hyperthermia therapy","author":"Zhang","year":"2023","journal-title":"Adv. Mater."},{"issue":"4","key":"10.1016\/j.bioactmat.2024.10.029_bib32","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s11684-020-0760-2","article-title":"Intratumor heterogeneity, microenvironment, and mechanisms of drug resistance in glioma recurrence and evolution","volume":"15","author":"Bao","year":"2021","journal-title":"Front. Med."},{"issue":"45","key":"10.1016\/j.bioactmat.2024.10.029_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202205924","article-title":"Etching bulk covalent organic frameworks into nanoparticles of uniform and controllable size by the molecular exchange etching method for sonodynamic and immune combination antitumor therapy","volume":"34","author":"Wang","year":"2022","journal-title":"Adv. Mater."},{"issue":"13","key":"10.1016\/j.bioactmat.2024.10.029_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202108174","article-title":"Engineering multienzyme-mimicking covalent organic frameworks as pyroptosis inducers for boosting antitumor immunity","volume":"34","author":"Zhang","year":"2022","journal-title":"Adv. Mater."},{"issue":"2","key":"10.1016\/j.bioactmat.2024.10.029_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/VIW.20200121","article-title":"Type I AIE photosensitizers: mechanism and application","volume":"3","author":"Li","year":"2022","journal-title":"View"},{"issue":"5","key":"10.1016\/j.bioactmat.2024.10.029_bib36","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jcc.22885","article-title":"Multiwfn: a multifunctional wavefunction analyzer","volume":"33","author":"Lu","year":"2012","journal-title":"J. Comput. Chem."},{"issue":"17","key":"10.1016\/j.bioactmat.2024.10.029_bib37","doi-asserted-by":"crossref","first-page":"9642","DOI":"10.1002\/anie.202016618","article-title":"Covalent organic frameworks enabling site isolation of viologen-derived electron-transfer mediators for stable photocatalytic hydrogen evolution","volume":"60","author":"Mi","year":"2021","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.10.029_bib38","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/s41467-022-29076-z","article-title":"In situ photodeposition of platinum clusters on a covalent organic framework for photocatalytic hydrogen production","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.10.029_bib39","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.1038\/s41467-022-34358-7","article-title":"Stereoisomeric engineering of aggregation-induced emission photosensitizers towards fungal killing","volume":"13","author":"Zhu","year":"2022","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bioactmat.2024.10.029_bib40","first-page":"624","article-title":"High-affinity mutant Interleukin-13 targeted CAR T cells enhance delivery of clickable biodegradable fluorescent nanoparticles to glioblastoma","volume":"5","author":"Kim","year":"2020","journal-title":"Bioact. Mater."},{"issue":"4","key":"10.1016\/j.bioactmat.2024.10.029_bib41","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1021\/acsnano.2c09931","article-title":"A nanotherapy of octanoic acid ameliorates cardiac arrest\/cardiopulmonary resuscitation-induced brain injury via RVG29- and neutrophil membrane-mediated injury relay targeting","volume":"17","author":"Yang","year":"2023","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.bioactmat.2024.10.029_bib42","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.ccell.2022.08.012","article-title":"Increased glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal Cathepsin B to promote cancer metastasis and chemoresistance","volume":"40","author":"Shi","year":"2022","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.bioactmat.2024.10.029_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk2285","article-title":"Atypical inflammatory kinase IKBKE phosphorylates and inactivates FoxA1 to promote liver tumorigenesis","volume":"10","author":"Gao","year":"2024","journal-title":"Sci. Adv."},{"issue":"4","key":"10.1016\/j.bioactmat.2024.10.029_bib44","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1021\/cr5004198","article-title":"Nanoparticles in photodynamic therapy","volume":"115","author":"Lucky","year":"2015","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.10.029_bib45","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/s41467-024-44963-3","article-title":"Redox-responsive polymer micelles co-encapsulating immune checkpoint inhibitors and chemotherapeutic agents for glioblastoma therapy","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bioactmat.2024.10.029_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ntm.2023.100022","article-title":"Advancements in modifying the efficacy of immunotherapies through the thermal effects of nanomaterials","volume":"2","author":"Lei","year":"2023","journal-title":"Nano TransMed"},{"issue":"15","key":"10.1016\/j.bioactmat.2024.10.029_bib47","doi-asserted-by":"crossref","DOI":"10.1063\/1.3382344","article-title":"A consistent and accurate ab initio parametrization of density functional dispersion correction (DFT-D) for the 94 elements H-Pu","volume":"132","author":"Grimme","year":"2010","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.bioactmat.2024.10.029_bib48","first-page":"358","article-title":"Covalent organic framework nanomedicines: biocompatibility for advanced nanocarriers and cancer theranostics applications","volume":"21","author":"Singh","year":"2023","journal-title":"Bioact. Mater."}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X24004821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X24004821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T10:51:54Z","timestamp":1735555914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X24004821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":48,"alternative-id":["S2452199X24004821"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2024.10.029","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b2-Ketoenamine covalent organic framework nanoplatform combined with immune checkpoint blockade via photodynamic immunotherapy inhibit glioblastoma progression","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2024.10.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}